Araújo, Aurigena AntunesSouza, Graziene Lopes deSouza, Tatiana OliveiraBrito, Gerly Anne de CastroAragão, Karoline SabóiaMedeiros, Caroline Addison Xavier deLourenço, YriuAlves, Maria do Socorro Costa FeitosaAraújo Jr, Raimundo Fernandes de2018-06-162018-06-162013-06-19ARAÚJO, Aurigena Antunes de et al. Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis. Naunyn-Schmiedeberg's Archives of Pharmacology, p. 875-84, 2013. Disponível em: <https://link.springer.com/article/10.1007/s00210-013-0886-8>. Acesso em: 14 mar. 2018.1432-1912https://repositorio.ufrn.br/jspui/handle/123456789/25416Acesso AbertoExperimental periodontal diseaseCitocinesImmunohistochemicalLipid peroxidantOlmesartanOlmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitisarticlehttps://doi.org/10.1007/s00210-013-0886-8